Halozyme Therapeutics
HALO
#1792
Rank
โ‚ฌ10.47 B
Marketcap
92,32ย โ‚ฌ
Share price
2.72%
Change (1 day)
55.87%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: โ‚ฌ10.47 Billion

As of August 2026 Halozyme Therapeutics has a market cap of โ‚ฌ10.47 Billion. This makes Halozyme Therapeutics the world's 1792th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ10.47 B51.99%
2025โ‚ฌ6.89 B17.16%
2024โ‚ฌ5.88 B33.24%
2023โ‚ฌ4.41 B-38.42%
2022โ‚ฌ7.17 B43.48%
2021โ‚ฌ4.99 B6.49%
2020โ‚ฌ4.69 B116.94%
2019โ‚ฌ2.16 B16.91%
2018โ‚ฌ1.85 B-23%
2017โ‚ฌ2.40 B97.63%
2016โ‚ฌ1.21 B-40.12%
2015โ‚ฌ2.03 B103.62%
2014โ‚ฌ0.99 B-19.76%
2013โ‚ฌ1.24 B117.44%
2012โ‚ฌ0.57 B-24.71%
2011โ‚ฌ0.75 B26.79%
2010โ‚ฌ0.59 B59.44%
2009โ‚ฌ0.37 B15.14%
2008โ‚ฌ0.32 B-14%
2007โ‚ฌ0.37 B-9.54%
2006โ‚ฌ0.41 B353.05%
2005โ‚ฌ92.56 M16%
2004โ‚ฌ79.79 M

End of Day market cap according to different sources

On Aug 18th, 2026 the market cap of Halozyme Therapeutics was reported to be:

โ‚ฌ10.20 Billion
by Nasdaq info icon info icon
โ‚ฌ10.20 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ563.98 B 5,282.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ137.75 B 1,214.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ977.00 B 9,223.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ94.07 B 797.85%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
โ‚ฌ11.77 B 12.36%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚ฌ1.21 B-88.43%๐Ÿ‡บ๐Ÿ‡ธ USA